Joy Kong, MD argues stem cell therapies address root causes of disease, potentially letting patients stop medications. This threatens pharma profits. Kong addresses misconceptions about ethics and sources, noting newer extraction techniques produce more potent cells.
Stem cells have the potential to really treat the root causes of a lot of conditions and actually getting people to be completely off medication. So actually, healing is not good for a bottom line for any of the existing companies that's making billions of dollars from the existing model. So it's not good for business for these forces who are very powerful. So that's one reason. Another reason is just a new science. A lot of people don't understand it, and they think it's new, or some even think that there's something unethical about it only because they don't understand the current state of stem cell therapy, that cells are either obtained from a person's own body or obtained from birth tissue, which usually is tossed in the waste, biological waste basket. But now we can actually extract more really powerful cells from these tissues. So there are a lot of misconceptions. That's why it hasn't been as prominent.
